Sovargen

Advertisement

cGxPJobs Banner

Kazia Advances Paxalisib in Rare Seizure Disorders

Sydney, Australia, September 21, 2026 Kazia Therapeutics Limited has announced that its development partner Sovargen Co., Ltd. has dosed...

By cGxPwire Editor
September 24, 2026

Read More

Advertisement

cGxPJobs

Directory